CDK4/6-IN-3

• UNSPSC Description:

  CDK4/6-IN-3 is a brain-penetrant CDK4/CDK6 inhibitor with Kis of i of 110 nM. CDK4/6-IN-3 can be used for the treatment of glioblastoma[1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk4-6-in-3.html

• Solubility:

  10 mM in DMSO

• Smiles:

  FC1=CN=C(NC2=NC=C(N3CC4(CN(CC)C4)C3)C=C2)N=C1C5=C([C@H](C)CCCC6)N6N=C5

• Molecular Weight:

  462.57

• References & Citations:

  [1]Bronner SM, et al. Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2294-2301.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2366237-37-6